Theranostics 2013; 3(8):616-617. doi:10.7150/thno.7020

Editorial

Nanoparticle-based Monitoring of Stem Cell Therapy

Chenjie Xu1✉, Weian Zhao2 ✉

1. Division of Bioengineering, School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore 637457.
2. Sue and Bill Gross Stem Cell Research Center, Chao Family Comprehensive Cancer Center, Edwards Lifesciences Center for Advanced Cardiovascular Technology, Department of Biomedical Engineering, and Department of Pharmaceutical Sciences, University of California, Irvine, CA USA 92697.

Abstract

This theme issue provides a timely overview on the current status of stem cell tracking with the nanoparticle-based contrast agents.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Xu C, Zhao W. Nanoparticle-based Monitoring of Stem Cell Therapy. Theranostics 2013; 3(8):616-617. doi:10.7150/thno.7020. Available from http://www.thno.org/v03p0616.htm